ArticleFuture oncology (London, England)2024

Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study.

Isabel María Carrión-Madroñal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.